4.6 Article

Development and Validation of a Lifetime Risk Model for Kidney Failure and Treatment Benefit in Type 2 Diabetes 10-Year and Lifetime Risk Prediction Models

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Cardiac & Cardiovascular Systems

Association of SGLT2 Inhibitors With Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes A Meta-analysis

Darren K. McGuire et al.

Summary: SGLT2 inhibitors were found to reduce the risk of major adverse CV events and showed significant heterogeneity in associations with CV death. The most consistent benefit of this class of drugs was a reduction in risk for heart failure and kidney outcomes, with heart failure risk reduction being the most consistent observation across the trials.

JAMA CARDIOLOGY (2021)

Review Medicine, General & Internal

Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials

Suetonia C. Palmer et al.

Summary: This network meta-analysis evaluated the effectiveness of SGLT-2 inhibitors and GLP-1 receptor agonists in patients with type 2 diabetes at varying cardiovascular and renal risk levels. The study found that both classes of drugs lowered mortality and improved cardiovascular outcomes, with notable differences in effects between the two agents. Additional benefits and adverse effects varied across different risk groups.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Medicine, General & Internal

Performance of prediction models for nephropathy in people with type 2 diabetes: systematic review and external validation study

Roderick C. Slieker et al.

Summary: This study identified multiple prediction models for albuminuria, diabetic kidney disease, chronic kidney disease, and end stage renal disease. In external validation, discrimination and calibration varied considerably across prediction horizons and models for albuminuria, diabetic kidney disease, and chronic kidney disease. However, specific models showed good discrimination and calibration across the three prediction horizons for each outcome, with clinically accessible predictors, making them applicable in a clinical setting.

BMJ-BRITISH MEDICAL JOURNAL (2021)

Review Endocrinology & Metabolism

Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials

Naveed Sattar et al.

Summary: The meta-analysis showed that GLP-1 receptor agonists can reduce the risk of major adverse cardiovascular events, all-cause mortality, hospital admission for heart failure, and worsening kidney function in patients with type 2 diabetes, regardless of structural homology.

LANCET DIABETES & ENDOCRINOLOGY (2021)

Article Urology & Nephrology

CKD Prevalence in the Military Health System: Coded Versus Uncoded CKD

Jenna M. Norton et al.

Summary: This study found a high proportion of unrecorded CKD patients, with those undiagnosed often being younger, female, and more active despite having risk factors for CKD. This suggests that clinicians may be missing CKD in traditionally lower risk groups.

KIDNEY MEDICINE (2021)

Article Urology & Nephrology

The ERA-EDTA Registry Annual Report 2018: a summary

Anneke Kramer et al.

Summary: Based on the 2018 data, kidney replacement therapy is prevalent in Europe and countries bordering the Mediterranean Sea, with an incidence rate of 129 per million population. Most patients choose hemodialysis at the onset of treatment, and kidney transplant recipients have a higher survival rate.

CLINICAL KIDNEY JOURNAL (2021)

Article Urology & Nephrology

Performance of GFR Slope as a Surrogate End Point for Kidney Disease Progression in Clinical Trials: A Statistical Simulation

Tom Greene et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2019)

Article Medicine, General & Internal

PROBAST: A Tool to Assess the Risk of Bias and Applicability of Prediction Model Studies

Robert F. Wolff et al.

ANNALS OF INTERNAL MEDICINE (2019)

Article Medicine, General & Internal

How to translate clinical trial results into gain in healthy life expectancy for individual patients

Jannick A. N. Dorresteijn et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Medicine, General & Internal

How to translate clinical trial results into gain in healthy life expectancy for individual patients

Jannick A. N. Dorresteijn et al.

BMJ-BRITISH MEDICAL JOURNAL (2016)

Article Endocrinology & Metabolism

Derivation and Validation of a Renal Risk Score for People With Type 2 Diabetes

C. Raina Elley et al.

DIABETES CARE (2013)

Review Medicine, General & Internal

Smoking and All-Cause Mortality in Older People Systematic Review and Meta-analysis

Carolin Gellert et al.

ARCHIVES OF INTERNAL MEDICINE (2012)

Article Medicine, General & Internal

A New Equation to Estimate Glomerular Filtration Rate

Andrew S. Levey et al.

ANNALS OF INTERNAL MEDICINE (2009)

Article Public, Environmental & Occupational Health

Prognostic Models With Competing Risks Methods and Application to Coronary Risk Prediction

Marcel Wolbers et al.

EPIDEMIOLOGY (2009)

Article Cardiac & Cardiovascular Systems

Beyond Low-Density Lipoprotein Cholesterol

Benoit J. Arsenault et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)

Article Medicine, General & Internal

Lifetime risk for diabetes mellitus in the United States

KMV Narayan et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)